| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Intraabdominal Infections | 7 | 2019 | 90 | 3.23 | Why? |
| Tetracyclines | 2 | 2019 | 82 | 0.86 | Why? |
| Phenazines | 1 | 2019 | 12 | 0.81 | Why? |
| Peritonitis | 2 | 2019 | 217 | 0.81 | Why? |
| Gentian Violet | 1 | 2019 | 18 | 0.80 | Why? |
| Wounds, Stab | 1 | 2019 | 36 | 0.79 | Why? |
| Anti-Bacterial Agents | 13 | 2021 | 10083 | 0.78 | Why? |
| Thoracic Injuries | 1 | 2019 | 63 | 0.75 | Why? |
| Pneumonia, Bacterial | 3 | 2021 | 843 | 0.73 | Why? |
| Ventilators, Mechanical | 2 | 2021 | 2193 | 0.70 | Why? |
| beta-Lactamase Inhibitors | 1 | 2018 | 104 | 0.70 | Why? |
| Pneumonia, Ventilator-Associated | 3 | 2020 | 861 | 0.67 | Why? |
| Cholesterol, HDL | 1 | 2020 | 439 | 0.67 | Why? |
| Skin Diseases, Infectious | 1 | 2018 | 77 | 0.65 | Why? |
| Pseudomonas Infections | 2 | 2018 | 425 | 0.65 | Why? |
| Soft Tissue Infections | 1 | 2018 | 116 | 0.64 | Why? |
| Cholesterol, LDL | 1 | 2020 | 499 | 0.63 | Why? |
| Diaphragm | 1 | 2019 | 232 | 0.62 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.59 | Why? |
| Candidiasis | 2 | 2017 | 334 | 0.55 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 0.53 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.53 | Why? |
| Anesthesia, Obstetrical | 1 | 2017 | 230 | 0.53 | Why? |
| Bacterial Infections | 5 | 2021 | 2229 | 0.52 | Why? |
| Critical Illness | 7 | 2021 | 17281 | 0.50 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.49 | Why? |
| Candidiasis, Invasive | 3 | 2018 | 107 | 0.48 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.45 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.39 | Why? |
| Intensive Care Units | 15 | 2021 | 29594 | 0.38 | Why? |
| Echinocandins | 3 | 2018 | 139 | 0.36 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.34 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.33 | Why? |
| Health Services Needs and Demand | 2 | 2020 | 3419 | 0.31 | Why? |
| Occupational Diseases | 2 | 2020 | 2787 | 0.30 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.30 | Why? |
| Paris | 2 | 2019 | 1287 | 0.29 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.29 | Why? |
| France | 9 | 2021 | 12074 | 0.28 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.27 | Why? |
| Lung Transplantation | 3 | 2021 | 1554 | 0.25 | Why? |
| Disease Management | 3 | 2019 | 6841 | 0.25 | Why? |
| Pseudomonas aeruginosa | 2 | 2018 | 652 | 0.24 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.23 | Why? |
| Anesthesia, Inhalation | 1 | 2020 | 49 | 0.21 | Why? |
| Personnel Management | 1 | 2020 | 115 | 0.20 | Why? |
| Equivalence Trials as Topic | 1 | 2020 | 242 | 0.20 | Why? |
| Nurse Anesthetists | 1 | 2020 | 62 | 0.20 | Why? |
| Lipoproteins, HDL | 1 | 2021 | 154 | 0.19 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2018 | 36 | 0.19 | Why? |
| Abdominal Wound Closure Techniques | 1 | 2018 | 19 | 0.18 | Why? |
| Prophylactic Surgical Procedures | 1 | 2018 | 13 | 0.18 | Why? |
| Simplified Acute Physiology Score | 1 | 2018 | 102 | 0.18 | Why? |
| Virus Physiological Phenomena | 1 | 2020 | 155 | 0.18 | Why? |
| Antifungal Agents | 3 | 2018 | 1828 | 0.18 | Why? |
| Time | 1 | 2021 | 631 | 0.18 | Why? |
| Mycological Typing Techniques | 1 | 2017 | 38 | 0.18 | Why? |
| Prospective Studies | 10 | 2020 | 43301 | 0.18 | Why? |
| Extravascular Lung Water | 1 | 2017 | 32 | 0.18 | Why? |
| Antiparasitic Agents | 1 | 2020 | 267 | 0.17 | Why? |
| Reflex, Pupillary | 1 | 2017 | 33 | 0.17 | Why? |
| Azabicyclo Compounds | 1 | 2018 | 91 | 0.17 | Why? |
| Drug Resistance, Multiple, Fungal | 1 | 2017 | 45 | 0.17 | Why? |
| Analgesia | 1 | 2020 | 211 | 0.17 | Why? |
| Ceftazidime | 1 | 2018 | 134 | 0.17 | Why? |
| Analgesia, Epidural | 1 | 2017 | 63 | 0.17 | Why? |
| Anticoagulants | 2 | 2018 | 9563 | 0.16 | Why? |
| Humans | 44 | 2021 | 930598 | 0.16 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.16 | Why? |
| Hyperkalemia | 1 | 2018 | 140 | 0.16 | Why? |
| Bronchitis | 1 | 2018 | 146 | 0.16 | Why? |
| Cephalosporins | 1 | 2018 | 250 | 0.16 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.16 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.16 | Why? |
| Bacterial Typing Techniques | 1 | 2017 | 273 | 0.16 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.16 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.15 | Why? |
| Antibiotic Prophylaxis | 1 | 2019 | 399 | 0.15 | Why? |
| Female | 27 | 2021 | 380317 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Anesthesia, General | 2 | 2017 | 470 | 0.15 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2021 | 1439 | 0.15 | Why? |
| Blood Loss, Surgical | 1 | 2017 | 211 | 0.15 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.15 | Why? |
| APACHE | 1 | 2018 | 682 | 0.15 | Why? |
| Potassium | 1 | 2018 | 325 | 0.15 | Why? |
| Drug Therapy | 1 | 2018 | 280 | 0.14 | Why? |
| Male | 25 | 2021 | 367725 | 0.14 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.14 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.14 | Why? |
| Adrenergic beta-Antagonists | 1 | 2018 | 465 | 0.14 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.13 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.13 | Why? |
| Sweden | 1 | 2021 | 1969 | 0.13 | Why? |
| Aged | 17 | 2021 | 215776 | 0.13 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2018 | 451 | 0.13 | Why? |
| Drug Administration Schedule | 2 | 2017 | 2324 | 0.13 | Why? |
| Bacteria | 2 | 2021 | 1897 | 0.12 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.11 | Why? |
| Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.11 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.11 | Why? |
| Risk | 2 | 2020 | 5288 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.10 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.10 | Why? |
| Drug Overdose | 1 | 2017 | 583 | 0.10 | Why? |
| Hospital Mortality | 4 | 2018 | 22087 | 0.10 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.10 | Why? |
| Anesthesia | 1 | 2020 | 1236 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.09 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Cross Infection | 4 | 2020 | 8675 | 0.09 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.09 | Why? |
| Cardiac Surgical Procedures | 2 | 2019 | 1931 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Delivery, Obstetric | 1 | 2017 | 1292 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.09 | Why? |
| Guidelines as Topic | 2 | 2018 | 2844 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.08 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.08 | Why? |
| Obesity, Morbid | 1 | 2018 | 1340 | 0.08 | Why? |
| Nursing Staff, Hospital | 1 | 2020 | 1554 | 0.08 | Why? |
| Postoperative Period | 2 | 2019 | 651 | 0.08 | Why? |
| Time-to-Treatment | 2 | 2020 | 5883 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.08 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.07 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.07 | Why? |
| Fear | 1 | 2020 | 3607 | 0.07 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.07 | Why? |
| Time Factors | 5 | 2019 | 31397 | 0.07 | Why? |
| Elective Surgical Procedures | 2 | 2020 | 5338 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Candida | 2 | 2018 | 425 | 0.06 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2019 | 2963 | 0.06 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.06 | Why? |
| Adult | 7 | 2020 | 244371 | 0.05 | Why? |
| Aryldialkylphosphatase | 1 | 2021 | 61 | 0.05 | Why? |
| Registries | 1 | 2021 | 12327 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Professional Staff Committees | 1 | 2020 | 94 | 0.05 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.05 | Why? |
| Apolipoprotein A-I | 1 | 2021 | 148 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2019 | 5762 | 0.05 | Why? |
| Serum Amyloid A Protein | 1 | 2021 | 211 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.05 | Why? |
| Mice, Obese | 1 | 2018 | 29 | 0.05 | Why? |
| Abdominal Cavity | 1 | 2018 | 22 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| Thoracic Nerves | 1 | 2017 | 4 | 0.05 | Why? |
| Consciousness Monitors | 1 | 2017 | 11 | 0.05 | Why? |
| Ulnar Nerve | 1 | 2017 | 12 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.04 | Why? |
| Thermodilution | 1 | 2017 | 62 | 0.04 | Why? |
| Abortion, Therapeutic | 1 | 2017 | 42 | 0.04 | Why? |
| Intra-Abdominal Hypertension | 1 | 2018 | 36 | 0.04 | Why? |
| Median Nerve | 1 | 2017 | 18 | 0.04 | Why? |
| Pregnancy | 2 | 2017 | 23879 | 0.04 | Why? |
| Universal Precautions | 1 | 2020 | 293 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.04 | Why? |
| Anxiety | 2 | 2021 | 17311 | 0.04 | Why? |
| Electric Stimulation | 1 | 2017 | 84 | 0.04 | Why? |
| alpha 1-Antitrypsin | 1 | 2021 | 264 | 0.04 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.04 | Why? |
| Negative-Pressure Wound Therapy | 1 | 2018 | 66 | 0.04 | Why? |
| Chromatography, Liquid | 1 | 2021 | 640 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Fluconazole | 1 | 2018 | 145 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Hemofiltration | 1 | 2018 | 155 | 0.04 | Why? |
| Drug Resistance, Fungal | 1 | 2018 | 191 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Cardiopulmonary Bypass | 1 | 2017 | 158 | 0.04 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.04 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Azoles | 1 | 2017 | 185 | 0.04 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.04 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.04 | Why? |
| Survival Rate | 2 | 2019 | 9206 | 0.04 | Why? |
| Cardiotoxicity | 1 | 2018 | 365 | 0.03 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.03 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Informed Consent | 1 | 2020 | 890 | 0.03 | Why? |
| Antimicrobial Stewardship | 1 | 2021 | 931 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Resuscitation | 1 | 2018 | 638 | 0.03 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Belgium | 1 | 2018 | 2064 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.03 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.03 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.03 | Why? |
| Preoperative Care | 1 | 2020 | 1515 | 0.03 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.02 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.02 | Why? |
| Operating Rooms | 1 | 2020 | 1841 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.02 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Critical Care | 2 | 2019 | 14081 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.02 | Why? |
| Adaptation, Psychological | 1 | 2021 | 4996 | 0.02 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |